Corona Remedies IPO Subscription
ListedUpdated 15 December 2025, 9:15 AM IST· Mainboard
Corona Remedies IPO subscription closed on 10 December 2025 at 144.49x overall by shares. QIB demand came in at 293.80x, NII at 220.18x, and retail at 30.29x. See Retail, SHNI, and BHNI allotment chances in the table…
Corona Remedies IPO subscription closed on 10 December 2025 at 144.49x overall by shares. QIB demand came in at 293.80x, NII at 220.18x, and retail at 30.29x. See Retail, SHNI, and BHNI allotment chances in the table below.
Show moreShow less
Allotment date is 11 December 2025. Listing date on NSE and BSE is 15 December 2025.
Corona Remedies IPO Day-wise Subscription
Daily QIB, NII, Retail, and overall subscription as bids come in
| Day | QIB | NII | Retail | Overall |
|---|---|---|---|---|
| Day 1 - 8 Dec 2025 | 0.00x | 0.84x | 0.96x | 0.67x |
| Day 2 - 9 Dec 2025 | 1.76x | 28.37x | 6.90x | 9.96x |
| Day 3 - 10 Dec 2025 | 293.80x | 220.18x | 30.39x | 144.54x |
Corona Remedies IPO Allotment Chances
Retail, SHNI, and BHNI chances based on application subscription
Corona Remedies IPO allotment chances for Retail, SHNI, and BHNI. All three use lottery when the category is oversubscribed.
| Category | Subscription (Apps) | Allotment Chances |
|---|---|---|
| Retail | 24.81x | 1 in 25 |
| SHNI (Rs 2L to Rs 10L) | 160.34x | 1 in 160 |
| BHNI (above Rs 10L) | 49.76x | 1 in 50 |
Chances use application subscription (how many bids came in), not share or amount figures. If you get allotment, you get at least one lot. Higher subscription means lower chance per PAN.
Check the Corona Remedies IPO Allotment Status page from 11 December 2025 for your result.
Corona Remedies IPO Subscription by Amount
Category-wise subscription based on amount applied at issue price Rs 1,062.00
| Category | Amount Offered | Amount Applied | Subscription |
|---|---|---|---|
| QIB | Rs 129.75 Cr | Rs 38,119.37 Cr | 293.80x |
| FII | - | Rs 9,265.99 Cr | - |
| DFI | - | Rs 16,543.28 Cr | - |
| Mutual Funds | - | Rs 2,339.56 Cr | - |
| Other | - | Rs 9,970.54 Cr | - |
| NII | Rs 97.38 Cr | Rs 21,441.47 Cr | 220.18x |
| bNII (above Rs 10L) | Rs 64.92 Cr | Rs 16,014.25 Cr | 246.67x |
| Corporate | - | Rs 134.10 Cr | - |
| Individual | - | Rs 14,988.40 Cr | - |
| Other | - | Rs 891.75 Cr | - |
| sNII (Rs 2L to Rs 10L) | Rs 32.46 Cr | Rs 5,427.21 Cr | 167.20x |
| Corporate | - | Rs 10.02 Cr | - |
| Individual | - | Rs 5,171.45 Cr | - |
| Other | - | Rs 245.74 Cr | - |
| Retail | Rs 227.22 Cr | Rs 6,881.97 Cr | 30.29x |
| Cut-off price | - | Rs 5,709.31 Cr | - |
| Fixed price | - | Rs 1,172.66 Cr | - |
| Employee | Rs 6.16 Cr | Rs 95.89 Cr | 15.56x |
| Cut-off price | - | Rs 76.12 Cr | - |
| Fixed price | - | Rs 19.77 Cr | - |
| Total | Rs 460.51 Cr | Rs 66,538.70 Cr | 144.49x |
Corona Remedies IPO Subscription by Applications
Category-wise subscription based on applications received
| Category | Applications Offered | Applications Received | Subscription |
|---|---|---|---|
| QIB | 12,21,729 | 6,584 | 0.01x |
| FII | - | 144 | - |
| DFI | - | 97 | - |
| Mutual Funds | - | 31 | - |
| Other | - | 6,312 | - |
| NII | 4,678 | 4,05,165 | 86.61x |
| bNII (above Rs 10L) | 3,119 | 1,55,201 | 49.76x |
| Corporate | - | 1,097 | - |
| Individual | - | 1,45,362 | - |
| Other | - | 8,742 | - |
| sNII (Rs 2L to Rs 10L) | 1,559 | 2,49,964 | 160.34x |
| Corporate | - | 412 | - |
| Individual | - | 2,37,973 | - |
| Other | - | 11,579 | - |
| Retail | 1,52,827 | 37,91,888 | 24.81x |
| Cut-off price | - | 31,15,556 | - |
| Fixed price | - | 6,76,332 | - |
| Employee | 4,145 | 35,562 | 8.58x |
| Cut-off price | - | 29,450 | - |
| Fixed price | - | 6,112 | - |
| Total | 13,83,379 | 42,39,199 | 3.06x |
What Do These Subscription Numbers Mean?
144.49x overall by shares means bids covered about 144 times the shares on offer. Allotment chances depend on applications in each category.
QIB at 293.80x by shares shows institutional demand from mutual funds, FIIs, and banks.
NII covers bids above Rs 2 lakh (86.61x by applications). Split: SHNI 160.34x, BHNI 49.76x by applications. SHNI and BHNI allotment is by lottery.
At 24.81x subscription by applications, about 1 in 25 retail applicants may get allotment (~4% chance per application). Retail allotment is also by lottery.
Corona Remedies IPO GMP After Subscription
GMP for Corona Remedies IPO stands at Rs 342.00 today, giving an estimated listing price of Rs 1,404.00 per share.
A subscription of 144.49x combined with a GMP of 32.20% is a strong combination heading into listing. QIB demand above 50x in particular tends to support listing sentiment, as institutional investors are seen as informed buyers.
Track live GMP on the Corona Remedies IPO GMP Today page or the IPOwiz Live IPO GMP Tracker.
Corona Remedies IPO Key Dates
| Event | Date |
|---|---|
| IPO Open Date | 8 December 2025 |
| IPO Close Date | 10 December 2025 |
| Allotment Date | 11 December 2025 |
| Refund Initiation | 12 December 2025 |
| Share Credit to Demat | 12 December 2025 |
| Listing Date | 15 December 2025 |
| Minimum Investment | Rs 14,868.00 |
| Lot Size | 14 shares |
About Corona Remedies IPO
Corona Remedies Limited is an India-focused branded pharmaceutical company specializing in developing and marketing products across high-growth chronic therapeutic areas, primarily women’s healthcare, cardio-diabeto, pain management, and urology. The company is recognized as the second-fastest-growing among the top 30 firms in the Indian Pharmaceutical Market (IPM) by domestic sales. It operates two manufacturing facilities in Gujarat and Himachal Pradesh and leverages a pan-India marketing network of 2,671 medical representatives.
Understanding Subscription Categories
QIB - Qualified Institutional Buyers
Includes foreign institutional investors, domestic financial institutions, mutual funds, and other qualified institutions. QIB demand is considered the most reliable indicator of institutional confidence in an IPO.
NII - Non-Institutional Investors (SHNI & BHNI)
Investors bidding above Rs 2 lakh. Split into SHNI (Rs 2 lakh to Rs 10 lakh) and BHNI (above Rs 10 lakh). Both use lottery allotment when oversubscribed.
Retail - Retail Individual Investors
Investors bidding up to Rs 2 lakh per PAN. Allotment is by lottery when oversubscribed. Winners get at least one lot.
Corona Remedies IPO IPO Pages
Open related pages for this IPO: details, GMP, subscription, allotment, review, FAQ, registrar, timeline, and news.
Corona Remedies IPO Details
Issue size, price, financials, and company info
Corona Remedies IPO GMP
Live grey market premium and listing estimate
Corona Remedies IPO Subscription
QIB, NII, Retail, SHNI and BHNI subscription
Corona Remedies IPO Allotment
Allotment date, chances, and check by PAN
Corona Remedies IPO Review
SWOT, strengths, risks, and IPO review
Corona Remedies IPO FAQ
Common questions on dates, GMP, and allotment
Corona Remedies IPO Registrar
Registrar website and how to check allotment
Corona Remedies IPO Timeline
Open, close, allotment, and listing dates
Corona Remedies IPO News
Updates, blogs, and latest IPO news
Corona Remedies IPO Subscription FAQs
What is Corona Remedies IPO subscription status today?
Corona Remedies IPO subscription closed on 10 December 2025 with overall subscription of 144.49x (by shares) as of 27 August 2026, 4:32 AM IST. QIB 293.80x, NII 86.61x, Retail 24.81x.
What is the overall subscription of Corona Remedies IPO?
Corona Remedies IPO is subscribed 144.49x overall by shares at close on 10 December 2025. QIB 293.80x, NII 86.61x, and Retail 24.81x.
What is Corona Remedies IPO QIB subscription?
Corona Remedies IPO QIB (Qualified Institutional Buyers) subscription is 293.80x by shares. QIB includes mutual funds, FIIs, banks, and other institutions.
What is Corona Remedies IPO Retail subscription?
Corona Remedies IPO Retail subscription is 24.81x by applications. Retail bids are up to Rs 2 lakh per PAN.
What is Corona Remedies IPO NII, SHNI, and BHNI subscription?
Corona Remedies IPO NII subscription is 86.61x by applications. NII is bids above Rs 2 lakh, split into SHNI (Rs 2L to Rs 10L) at 160.34x and BHNI (above Rs 10L) at 49.76x.
What are Corona Remedies IPO retail allotment chances?
At 24.81x subscription by applications, about 1 in 25 retail applicants may get allotment (~4% chance per application). Allotment is by lottery. Share subscription was 30.29x. Allotment chances use applications, not share volume.
What are Corona Remedies IPO SHNI allotment chances?
At 160.34x subscription by applications, about 1 in 160 SHNI applicants may get allotment (~1% chance per application). Allotment is by lottery. Share subscription was 167.20x. Allotment chances use applications, not share volume.
What are Corona Remedies IPO BHNI allotment chances?
At 49.76x subscription by applications, about 1 in 50 BHNI applicants may get allotment (~2% chance per application). Allotment is by lottery. Share subscription was 246.67x. Allotment chances use applications, not share volume.
When is Corona Remedies IPO allotment date?
Corona Remedies IPO allotment date is 11 December 2025. Check Corona Remedies IPO Allotment Status on IPOwiz from that day using your PAN.
When does Corona Remedies IPO subscription close?
Corona Remedies IPO subscription closed on 10 December 2025. No new applications are accepted after the close.
What is Corona Remedies IPO GMP today?
Corona Remedies IPO GMP is ₹342 today (+32.20% over issue price ₹1,062). See live GMP on the Corona Remedies IPO GMP Today page.
What is Corona Remedies IPO issue price and lot size?
Corona Remedies IPO issue price is ₹1,062 per share. Lot size is 14 shares. Minimum investment is ₹14,868 per lot. Issue size: ₹655.37 Cr.
When is Corona Remedies IPO listing date?
Corona Remedies IPO listing date is 15 December 2025 on NSE and BSE. Allotment is on 11 December 2025.
How does subscription affect Corona Remedies IPO allotment?
In Corona Remedies IPO, Retail, SHNI, and BHNI allotment is by lottery when oversubscribed. Chances follow application subscription in each category, not share volume. At 144.49x overall, competition is very high.
For allotment results from 11 December 2025, visit the Corona Remedies IPO Allotment Status page. For listing day updates on 15 December 2025, download the IPOwiz App.
Sources
We match Corona Remedies IPO IPO numbers with official sources. For final dates and allotment results, double-check the registrar or exchange.
- SEBIRules for IPO allotment and disclosures in India
- NSEExchange notices, bidding data, and listing updates
- BSEExchange notices and IPO allotment check tools
- RHP / Offer DocumentCheck the company RHP on NSE/BSE or the IPO detail page
- IPO RegistrarRegistrar details are on the allotment page for this IPO
Also read our Editorial Policy, How GMP is calculated, How allotment chances work, and IPO fund allocation.
Reviewed by
Dinesh Agrawal · Lead IPO Analyst
15+ years in Indian markets and IPO research. He reviews subscription data before it goes live.